Allianz Asset Management
MRTX

Allianz Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Allianz Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34,670
Closed -$2.33M – 2179
2022
Q2 		$2.33M Buy
34,670
+19,555
+129% +$1.24M ﹤0.01% 1370
2022
Q1 		$1.24M Sell
15,115
-8,312
-35% -$850K ﹤0.01% 1768
2021
Q4 		$3.44M Sell
23,427
-8,994
-28% -$1.4M ﹤0.01% 1380
2021
Q3 		$5.74M Buy
32,421
+8,747
+37% +$1.41M ﹤0.01% 1231
2021
Q2 		$3.82M Buy
23,674
+143
+0.6% +$23K ﹤0.01% 1234
2021
Q1 		$4.03M Sell
23,531
-1,713
-7% -$339K ﹤0.01% 1151
2020
Q4 		$5.54M Buy
25,244
+2,814
+13% +$608K 0.01% 1013
2020
Q3 		$3.73M Buy
22,430
+123
+0.6% +$16.8K ﹤0.01% 1070
2020
Q2 		$2.55M Buy
22,307
+11,921
+115% +$1.16M ﹤0.01% 1512
2020
Q1 		$799K Sell
10,386
-23,321
-69% -$2.09M ﹤0.01% 1880
2019
Q4 		$4.34M Buy
33,707
+24,966
+286% +$2.41M ﹤0.01% 1548
2019
Q3 		$697K Buy
8,741
+78
+0.9% +$7.32K ﹤0.01% 2257
2019
Q2 		$892K Sell
8,663
-26,701
-76% -$2.08M ﹤0.01% 2180
2019
Q1 		$2.59M Buy
+35,364
New +$2.41M ﹤0.01% 1750

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Allianz Asset Management's MRTX Position: Q3 2022 in Review

Allianz Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022, closing a stake of 34,670 shares — an estimated $2.33M sold.

Allianz Asset Management first reported a position in MRTX in Q1 2019 and held it in 14 quarters. The position peaked at $5.74M in Q3 2021. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

  • Allianz Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Allianz Asset Management sold 34,670 Mirati Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.33M.
  • Allianz Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Allianz Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $5.74M in Q3 2021.
  • 243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.